abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

6 Aug 2007

Author:
CARE International, Oxfam, Ecumenical Advocacy Alliance

Indian ruling against pharmaceutical giant Novartis a victory for public health, say leading aid and advocacy agencies

Today's verdict by an Indian court against Novartis is an important victory for global public health, according to aid agencies CARE International and Oxfam International, and...the Ecumenical Advocacy Alliance…The agencies welcome Novartis's response today that it is unlikely to appeal the ruling…Novartis and the pharmaceutical industry have been given a clear message to respect developing countries' legal right to use the World Trade Organisation TRIPS (trade-related intellectual property) safeguards to strike the right balance between protecting public health and intellectual property…Novartis' legal challenge posed an enormous threat in developing countries to millions of people suffering from cancer, HIV and AIDS, diabetes and other diseases who are too poor to pay for expensive patented medicines.

Timeline